Merrion rates Parthus a buy
Merrion analyst John Coolican said despite a 12% revenue decline to $9.5m Parthus will “undoubtedly benefit from recovery when it happens. At these levels it is a clear buy.”
Mr Coolican says at $1.88 per share, Parthus has a market cap of $110m.